Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | zuclopenthixol | 5311507 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | zuclopenthixol | 5311507 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | zuclopenthixol | 5311507 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | zuclopenthixol | 5311507 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | zuclopenthixol | 5311507 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | zuclopenthixol | 5311507 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | zuclopenthixol | 5311507 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | fursultiamine | 3002119 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | fursultiamine | 3002119 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | fursultiamine | 3002119 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | fursultiamine | 3002119 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | tracazolate | 90454 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tracazolate | 90454 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | tracazolate | 90454 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pinacidil | 4826 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pinacidil | 4826 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pinacidil | 4826 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | pinacidil | 4826 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | pinacidil | 4826 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | pinacidil | 4826 | drug-path |